Abstract
In an attempt to explore the biosynthetic potential of endosymbiotic fungi, the secondary metabolite profiles of the endophytic fungus, Anteaglonium sp. FL0768, cultured under a variety of conditions were investigated. In potato dextrose broth (PDB) medium, Anteaglonium sp. FL0768 produced the heptaketides, herbaridine A (1), herbarin (2), 1-hydroxydehydroherbarin (3), scorpinone (4), and the methylated hexaketide 9S,11R-(+)-ascosalitoxin (5). Incorporation of commonly used epigenetic modifiers, 5-azacytidine and suberoylanilide hydroxamic acid, into the PDB culture medium of this fungus had no effect on its secondary metabolite profile. However, the histone acetyl transferase inhibitor, anacardic acid, slightly affected the metabolite profile affording scorpinone (4) as the major metabolite together with 1-hydroxydehydroherbarin (3) and a different methylated hexaketide, ascochitine (6). Intriguingly, incorporaion of Cu2+ into the PDB medium enhanced production of metabolites and drastically affected the biosynthetic pathway resulting in the production of pentaketide dimers, palmarumycin CE4 (7), palmarumycin CP4 (8), and palmarumycin CP1 (9), in addition to ascochitine (6). The structure of the new metabolite 7 was established with the help of spectroscopic data and by MnO2 oxidation to the known pentaketide dimer, palmarumycin CP3 (10). Biosynthetic pathways to some metabolites in Anteaglonium sp. FL0768 are presented and possible effects of AA and Cu2+ on these pathways are discussed.
Graphical abstract

1. Introduction
Fungi, especially those living in association with other organisms such as endophytic fungi, represent a rich and an underexplored source of biologically active small-molecule natural products with wide ranging applications (Gunatilaka, 2006; Kusari et al., 2013). In their mutualistic association, the host plant (macrophyte) protects and feeds the endophyte which in return produces bioactive metabolites, some of which are known to enhance the growth and competitiveness of the host plant, protect from pathogens and herbivores, and help to survive in harsh environments (Dreyfuss and Chapela, 1994; Gunatilaka, 2006). However, when cultured in artificially defined growth media not mimicking native habitats, many biosynthetic gene clusters encoding for secondary metabolites that increase competitiveness of these fungi in natural environments may remain silent (Hertweck, 2009). This was supported by the whole genome sequencing of several fungi which has resulted in the discovery of new biosynthetic gene clusters (Yaegashi et al., 2014). Realization that these gene clusters may remain silent until they are induced by an external trigger has recently led to intense research resulting in identification of a variety of strategies that have been successfully applied to activate these gene clusters. Some commonly employed strategies include application of epigenetic modifiers to activate silent biosynthetic pathways (Cichewicz, 2010) and simulation of natural gene cluster activating conditions by biotic (co-cultivation) (Pettit, 2009; Rateb et al., 2013), and abiotic (elicitation by chemical or physical means) (Pimental-Elardo et al., 2015) methods. Among these methods, incorporation of small-molecule modifiers into fungal culture media to manipulate epigenetic regulation of gene transcription has received considerable attention. These studies have focused on DNA methyl transferase (DNMT), histone deacetylase (HDAC), and proteasome inhibitors such as 5azacytidine (5-AZA) (Williams et al., 2008; Fisch et al., 2009; Wang et al., 2010; Yakasai et al., 2011; Beau et al., 2012; Chung et al., 2013; Zutz et al., 2013), suberoylanilide hydroxamic acid (SAHA) (Albright et al., 2015; Henrikson et al., 2009; Shwab et al., 2007; Vervoort et al., 2011) and bortezomib (VanderMolen et al., 2014), respectively. Recent studies have also suggested that Cu2+ has the ability to enhance structural diversity and production of fungal secondary metabolites (Paranagama et al., 2007b).
In this study we examined the effects of 5-AZA, SAHA, Cu2+ and the histone acetyltransferase (HAT) inhibitor, anacardic acid (AA) (Ghizzoni et al., 2010), on the production of secondary metabolites by the endophytic fungus, Anteaglonium sp. FL0768 (Anteagloniaceae, Pleosporales, Pezizomycotina, Ascomycota), isolated from the living photosynthetic tissue of sand spikemoss (Selaginella arenicola; Selaginellaceae) when cultured in a liquid medium containing potato dextrose broth (PDB). A previous study had shown that in solid potato dextrose agar (PDA) medium this fungus biosynthesized solely polyketides consisting of pentaketide dimers as major and heptaketides as minor metabolites (Xu et al., 2015).
2. Results and discussion
In order to test the effects of 5-AZA, SAHA, AA and Cu2+ on the secondary metabolome of Anteaglonium sp. FL0768, preliminary studies were first conducted in PDB medium to determine the time required for the optimum production of metabolites. It is known that in fungi optimum secondary metabolite production occurs usually at the end of their growth phase (Calvo et al., 2002) and our recent studies have suggested that for many fungi the highest yield of the extract containing metabolites could be obtained when glucose content in the medium reaches the lowest level (Wijeratne et al., 2014). When Anteaglonium sp. FL0768 was cultured in PDB, complete depletion of glucose in the medium occurred at the end of six weeks. Thus, in all subsequent experiments it was cultured for six weeks in this medium incorporating 5-AZA, SAHA, AA or Cu2+, filtered and the filtrates obtained were extracted with EtOAc and subjected to HPLC analysis and fractionation to isolate constituent metabolites. The resulting HPLC traces indicated that incorporation of AA (500 μM) (PDB+AA) and Cu2+ (250 μM) (PDB+ Cu2+) into the PDB medium affected the metabolite profiles of this fungus (Fig. 1) whereas the well-known smallmolecule epigenetic modifiers, 5-AZA and SAHA, had no such effect up to a concentration of 500 μM (data not shown).
Fig. 1.
HPLC profiles of the crude EtOAc extracts of Anteaglonium sp. FL0768 cultured in PDB (A), PDB+AA (B), and PDB+ Cu2+ (C).
Each of the extracts produced by Anteaglonium sp. FL0768 when cultured in PDB, PDB+AA, and PDB+Cu2+ were subjected to fractionation to isolate and characterize their constituent secondary metabolites (Fig. 2). All known compounds were identified by comparison of their spectroscopic data (UV, 1H NMR and LR-MS) with those reported. This led to the identification of the heptaketide, scorpinone (4) (Choshi et al., 2008; Wijeratne et al., 2010), as the major metabolite in PDB culture together with other heptaketides, herbaridine A (1) (Schüffler et al., 2009), herbarin (2) (Paranagama et al., 2007a), 1-hydroxydehydroherbarin (3) (Paranagama et al., 2007a), and the trimethyl hexaketide, 9S,11R-(+)-ascosalitoxin (5) (Evidente et al., 1993) as minor constituents. Dehydroherbarin (3a) (Wijeratne et al., 2010) and 1-methoxydehydroherbarin (3b) (Wijeratne et al., 2010) encountered in this extract were suspected to be artifacts formed from 2 and 3, respectively, during the isolation process. Fractionation of the PDB+AA culture extract resulted in the isolation of scorpinone (4) as the major metabolite and 1-hydroxydehydroherbarin (3) and a different trimethyl hexaketide, ascochitine (6) (Evidente et al., 1993) as minor metabolites suggesting that the metabolite profile was slightly affected by this HAT inhibitor. Intriguingly, the HPLC profile of the EtOAc extract derived from PDB+Cu2+ culture was found to be drastically different from those of PDB and PDB+AA cultures (Fig. 1C). It was also significant that the yield of the crude EtOAc extract obtained from the PDB+Cu2+ culture was ca. six-fold higher compared to those resulting from the same volume of PDB and PDB+AA cultures. Fractionation of the PDB+Cu2+ culture extract by solvent−solvent partitioning, Sephadex LH-20 gel permeation, normal phase silica gel and reversed-phase RP-18 column chromatography, followed by HPLC purification afforded 4 and 6−9 of which 7 was found to be a new pentaketide dimer and was named palmarumycin CE4. Comparison of the spectroscopic data with those reported identified the known metabolites as scorpinone (4) (Choshi et al., 2008; Wijeratne et al., 2010), ascochitine (6) (Colombo et al., 1980), palmarumycin CP1 (8) (Krohn et al., 1994a), and palmarumycin CP4 (9) (Krohn et al., 1997).
Fig. 2.
Structures of compounds 1−10.
Palmarumycin CE4 (7), obtained as an off-white gum, analyzed for C20H16O5 by a combination of HRMS and NMR data, and indicated 13 degrees of unsaturation. Its 1H NMR spectrum showed signals due to six aromatic protons [δH 7.55 (1H, dd, J = 0.8, 8.6 Hz), 7.53 (1H, dd, J = 0.8, 8.3 Hz), 7.45 (1H, dd, J = 7.6, 8.3 Hz), 7.44 (1H, dd, J = 7.6, 8.6 Hz), 7.04 (1H, dd, J = 0.8, 7.6 Hz), 6.95 (1H, dd, J = 0.8, 7.6 Hz)], two coupled olefinic protons [δH 6.00 (1H, ddd, J = 1.2, 2.2, 10.0 Hz), 5.88 (1H, ddd, J = 2.2, 4.2, 10.0 Hz)], protons of a methylene group [δH 2.90 (1H, ddd, J = 1.0, 2.2, 18.3 Hz) and 2.67 (1H, ddd, J = 1.0, 3.4, 18.3 Hz)], and five aliphatic methine protons [δH 4.70 (1H, t, J = 4.2 Hz), 4.41 (1H, ddd, J = 2.2, 4.2, 4.2 Hz), 4.11 (1H, m), 3.14 (1H, brdd, J = 4.0, 5.0 Hz), 2.76 (1H, dt, J = 1.2, 4.2 Hz)]. The 13C NMR spectrum showed twenty signals, which when interpreted with the help of HSQC data suggested the presence of a ketone carbonyl (δC 214.7), ten aromatic carbons [δC 147.0 (C), 146.8 (C), 134.5 (C), 127.7 (CH), 127.4 (CH), 121.8 (CH), 121.2 (CH), 114.0 (C), 110.0 (CH), 109.3 (CH)], an acetal carbon (δC 105.9), and eight methine carbons (δC 137.5, 125.8, 75.9, 71.7, 69.6, 47.2, 47.0, 42.4) of which two were olefinic and three were oxygenated. These data indicated that 7 contained a 1,8-naphthalenediol spiroketal moiety (Xu et al., 2015). The planar structure of the upper bicyclic portion of 7 was elucidated as 2,3,4a,5,8,8a-hexahydro-5-hydroxy-2,8-epoxynaphthalene by careful analysis of its 1H−1H COSY and HMBC spectra (Fig. 3). 1D NOESY data were useful in determining the stereochemistry of this bicyclic moiety. The NOEs observed for H-5 (δH 4.11)/H-8a (δH 2.76), H-4a (δH 3.14)/H-8a, H-8 (δH 4.70)/H-8a, and H-5/H-4a confirmed that these four protons were located on the same side of the ring. The proton at C-2 (δH 4.41) showed NOEs with both protons of H2-3 suggesting that the oxygen at C-2 had axial orientation. The presence of an ether linkage between C-2 and C-8 was inferred by considering the degree of unsaturation, the cis-conformation of the upper bicyclic moiety, and the HMBC correlations of H-2/C-8 and H-8/C-2. These data suggested that 7 was structurally related to palmarumycin CP3 (10) (Xu et al., 2015), except that in 7 the CO group at C-5 of 10 was replaced with a CHOH. This was confirmed by the treatment of 7 with MnO2 to afforded its oxidation product in 73% yield which had spectroscopic (1H and 13C NMR, and MS) data identical with those reported for 10 (Krohn et al., 1994b; Xu et al., 2015). Thus, the structure of palmarumycin CE4 was established as (2β,4aα,5β,8β,8aα)-2,3,4a,5,8,8a-hexahydro-5-hydroxy-spiro [2,8-epoxynaphthalene]-1(4H)-2′-naphtho[1,8-de][1,3]dioxin-4-one (7) (Fig. 1).
Fig. 3.
Key 1H−1H COSY, HMBC, and NOE correlations for 7.
To the best of our knowledge this work constitutes the first use of the HAT inhibitor AA to manipulate the secondary metabolism of a fungus. However, in a recent study involving Streptomyces-induced production of secondary metabolites in Aspergillus nidulans, transcription of the fungal orsellinic acid producing gene (orsA) induced by the bacterium was shown to be inhibited by AA by blocking histone modification via a HAT complex; in contrast, SAHA was found to activate orsA gene without the need for co-incubation of the fungus with the bacterium (Nutzmann et al., 2011). In our previous work we found that incorporation of Cu2+ into the PDB culture medium of the rhizosphere fungus, Paraphaeosphaeria quadriseptata, significantly enhanced the production of monocillin I (Paranagama et al., 2007b), a heat-shock-inducing natural product capable of conferring thermotolerance to Arabidopsis by overexpression of the stress-related protein, Hsp101 (McLellan et al., 2007). The effect of Cu2+ in the production of monocillin I by P. quadriseptata was interpreted as due to its influence on superoxide dismutase (SOD) activity and by considering the role of this enzyme in the cellular adaptation to environmental stress (Paranagama et al., 2007b).
As apparent from the HPLC profiles of secondary metabolites produced by Anteaglonium sp. FL0768 (Fig. 1), incorporation of AA and Cu2+ into the culture medium appeared to have affected mainly the biosynthesis of scorpinone (4), 9S,11R-(+)-ascosalitoxin (5), ascochitine (6), palmarumycin CE4 (7) and palmarumycin CP4 (9). Labelling studies have suggested that 4 was biosynthesized from a heptaketide precursor (Van Wagoner et al., 2008), 6 was derived from a trimethyl-hexaketide precursor via (+)-ascosalitoxin (5) (Seibert et al., 2006), and biosynthesis of 9 involved phenolic oxidative dimerization of the pentaketide precursor, 1,8-dihydroxynaphthalene (DHN) (Bode and Zeeck, 2000) (Fig. 4). DHN, a reductive dehydration product of 1,3,6,8-tetrahydronaphthalene (THN), has also been shown to be the precursor of fungal melanin biosynthesis (Schumacher, 2016). It is noteworthy that under all culture conditions used the hyphae of Anteaglonium sp. FL0768 turned black during its growth indicating that it produced significant quantity of melanin (see Fig. S7, Supporting Information). It has recently been shown that in some fungi, the pentaketide THN was in fact derived from hexaketide and heptaketide precursors by the side-chain hydrolase-catalyzed removal of acetyl and acetoacetyl groups, respectively (Fujii et al., 2004; Vagstad et al., 2012) (Fig. 4). In contrast to PDB culture which contained mainly heptaketide metabolites, PDB+Cu2+ culture was found to be devoid of heptaketides, except for a trace amount of scorpinone (4), suggesting the possibility that incorporation of Cu2+ into PDB caused inhibition of polyketide synthase (PKS) of Anteaglonium sp. FL0768 involved in the production of heptaketides (Fig. 4). It is known that ketosynthase (KS) domain is the most important for the control of the chain length of polyketides, but product template (PT) domain (Newman et al., 2014) and thiohydrolase (Zabala et al., 2014) can also affect the chain length of polyketides. Thus, disruption of these domains and enzymes via oxidative stress caused by Cu2+ inhibiting PKS involved in heptaketide production in this fungus cannot be ruled out. The production of palmarumycin-type spirobisnaphthalenes (7–9) by Anteaglonium sp. FL0768 in PDB+Cu2+ suggested the possible role played by Cu2+ in their biosynthesis. It has been reported that Cu2+ enhanced the activity of fungal multi-copper oxidases (laccases) which are involved in melanin biosynthesis and known to catalyze one-electron oxidation of phenolic substrates (Upadhyay et al., 2013). Since the biosynthesis of dimeric pentaketide spirobisnaphthalenes has been known to involve phenolic oxidative coupling of DHN (Engelmann et al., 2015) (Fig. 4), it is very likely that Cu2+ played a major role in the production of palmarumycin-type metabolites (7–9) in Anteaglonium sp. FL0768. It is also noteworthy that both AA and Cu2+ induced the biosynthetic conversion of 5 to 6. Further studies are in progress to understand the effects of AA and Cu2+ in the production of polyketide metabolites in Anteaglonium sp. FL0768 and other fungal strains.
Fig. 4.
Biosynthetic routes to scorpinone (4), (+)-ascosalitoxin (5), ascochitine (6) and palmarumycin CP1 (8) from hexaketide and heptaketide precursors.
Several metabolites encountered in this study have been reported to have interesting biological activities. These included calmodulin inhibitory (Leyte-Lugo et al., 2012) and phytotoxic (Bode et al., 2000) activities of 9S,11R-(+)-ascosalitoxin (5), antibacterial (Kusnick et al., 2002), weakly cytotoxic (Von Woedtke et al., 2002), and MPtpB enzyme inhibitory (Seibert et al., 2006) activities of ascochitine (6), and weakly antibacterial (Aslan et al., 2011) and cytotoxic (Wipf et al., 2001) activities of palmarumycin CP1 (8). Metabolites 4 and 6−9 were evaluated for in vitro inhibition of cell proliferation/survival using a panel of six cancer cell lines including PC-3M (metastatic human prostate adenocarcinoma), NCI-H460 (human non-small cell lung cancer), SF-268 (human CNS glioma), MCF-7 (human breast cancer), and MDA-MB-231 (human breast adenocarcinoma). Among these only palmarumycin CP1 (8) exhibited cytotoxic activity below a concentration of 5.0 μg/mL against these cell lines (see Table S1, Supporting Information). When evaluated against the human Ewing’s sarcoma cell line CHP-100, 8 had shown strong cytotoxicity with an IC50 of 1.6 μM (Xu et al., 2015). It is noteworthy that palmarumycin CP1 (4) has been reported to exhibit antitumor activity through inhibition of TrxR-1 (thioredoxin reductase-1) activity (Powis et al., 2006).
This study is significant as it demonstrated for the first time that the HAT inhibitor, AA, is capable of affecting the metabolites produced by a filamentous fungus. Incorporation of the heavy metal salt, CuSO4, significantly enhanced secondary metabolite production by Anteaglonium sp. FL0768 in addition to producing a new metabolite. Applicability of these modifiers for production enhancement and structural diversification of secondary metabolites of other fungi is currently under investigation.
3. Experimental section
3.1. General experimental procedures
Optical rotations were measured at room temperature with a Jasco Dip-370 polarimeter using MeOH as the solvent. UV spectra were recorded with Shimadzu UV 2601 spectrophotometer. 1D and 2D NMR spectra were recorded with a Bruker Avance III 400 NMR instrument at 400 MHz for 1H NMR and 100 MHz for 13C NMR. Chemical shift values (δ) are given in parts per million (ppm) and the coupling constants are in Hz. Low-resolution and high-resolution MS were recorded on Shimadzu LCMS-DQ8000α and JEOL HX110A spectrometers, respectively. HPLC analyses were carried out on a Phenomenex Luna 5μ C18 (2) 100 Å 250 × 4.6 mm column with Hitachi L-6200A system consisting of a Hitachi L-4500 DAD detector, a Shimadzu ELSD-LT detector, and a Hitachi AS-4000 intelligent auto sampler. Analytical thin-layer chromatography (TLC) was carried out on silica gel 60 F254 aluminum-backed TLC plates (Merck). Preparative TLC was performed on Analtech silica gel 500 μm glass plates. Compounds were visualized with short-wavelength UV and by spraying with anisaldehyde-sulfuric acid spray reagent followed by heating until the spots appeared. Silica gel flash chromatography was accomplished using 230–400 mesh silica gel. Whatman LRP-2 was used for RP column chromatography. Sephadex LH-20 for gel-permeation chromatography was obtained from Amersham Biosciences. HPLC purifications was carried out on a 10 × 250 mm Phenomenex Luna 5μ C18 (2) 100 Å column with Waters Delta Prep system consisting of a PDA 996 detector. 5-Azacytidine (5-AZA) and suberoylanilide hydroxamic acid (SAHA) were purchased from Alfa Aesar and Cayman Chemical Company, respectively. Anarcardic acid (AA) used [containing a mixture of 2.2–3.0% saturated, 25.0–33.3% mono-unsaturated (8’), 17.8–32.1% di-unsaturated (8’,11’), and 36.3–50.4% tri-unsaturated (8’,11’,14’) (Mazzeto et al., 2009)] was a gift from Prof. Diego L. V. Oliveira of University of Ceará, Brazil.
3.2. Culture methods
The endophytic fungus, Anteaglonium sp. FL0768, isolated and identified as described previously (Xu et al., 2015), was grown on PDA for 14 days at 23 oC. The mycelia were scraped out and placed to Falcon tubes containing sterile water. The suspensions were vortexed for 1 min, and then strained using a 100 μM nylon cell strainer. The optical density (OD600) of final spore-hyphae suspensions was adjusted to 0.4 with sterile water and was used to inoculate liquid growth media (100 mL in 250 mL Erlenmeyer flasks) consisting of PDB, PDB+5-AZA (500 μM), PDB+SAHA (500 μM), PDB+AA (500 μM) and PDB+CuSO4 (250 μM). All small-scale experiments were conducted in triplicate (3 flasks for each of the above). For large-scale cultures 10.0 mL of spore-hyphae suspension (OD600 = 0.4) was added to nine 2.0 L Erlenmeyer flasks each containing 1.0 L of the respective culture medium. The flasks were shaken on a rotary shaker at 28 oC and 160 RPM until the cultures were ready for extraction. All cultures were grown for six weeks as complete depletion of glucose (as indicated by the glucose strip test) (Wijeratne et al., 2014) in PDB occurred at the end of this period.
3.3. Extraction and HPLC analysis of crude extracts
The medium of each flask from the above five small-scale cultures was separately filtered to remove mycelia and the resulting filtrate was extracted with EtOAc (3 × 600 mL). The combined EtOAc layer was washed with water (300 mL) and evaporated under reduced pressure providing the crude EtOAc extract. The calculated yields of crude EtOAc extracts/1.0 L of the culture medium were: PDB = 0.16 g; PDB+Cu2+ = 1.0 g; PDB+AA = 0.15 g. A small portion (1.0 mg) of crude extracts from each of the small-scale cultures was dissolved in HPLC grade MeOH (0.5 mL), centrifuged at 13 000 rpm for 3 min and the resulting supernatant was used for HPLC analysis. The analysis was performed by HPLC-PDA-ELSD on 20 μL of the extract using a C18 column and a gradient of MeOH:H2O (increasing linearly from 60% MeOH/H2O at 0.0 min to 100% MeOH at 45 min) at a flow rate of 0.7 mL/min and UV detection at 230 nm. Extracts derived from triplicate samples exhibited very similar HPLC profiles suggesting reproducibility of each of the small-scale experiments. The HPLC peak assignments were based on peak enhancement with isolated compounds.
3.4. Isolation of metabolites
The crude EtOAc extract (130.0 mg) derived from a PDB culture (9.0 L) was subjected to silica gel (20.0 g) column chromatography. Elution with 95:5 CHCl3-MeOH (200 mL) followed by MeOH afforded three fractions, fraction 1 (50.4 mg), fraction 2 (21.7 mg), and fraction 3 (60.1 mg). Fraction 1 was further separated by C-18 (10.0 g) reversed-phase column chromatography. Elution with 80% aq. MeOH afforded two fractions, 1–1 (19.2 mg) and 1–2 (26.8 mg). Further separation of fraction 1–1 was achieved by silica gel prep. TLC using 98:2 CHCl3-MeOH as eluent to give 4 (20.5 mg) and 3b (2.0 mg). Fraction 2 above and fraction 1–2 were found to have similar TLC profiles and therefore combined and purified by C18 RPHPLC [Phenomenex Luna 5 μ C18 (2) 100 Å 10 × 250 mm column, solvent system (60% aq. MeOH in 125 min and 70% aq. MeOH in 25–40 min), 3 mL/min, UV detection at 220 nm] to afford 1 (2.4 mg eluted at 9.8 min), 2 (3.4 mg; eluted at 14.9 min), 3 (3.0 mg; eluted at 24.5 min) and a mixture of two compounds (9.3 mg; eluted at 38.4 min). Purification of this mixture by silica gel prep. TLC (eluent: 98:2 CHCl3-MeOH) gave 5 (7.4 mg) and 3b (1.9 mg). The CDCl3 solution of 2 used for NMR spectroscopy was found to undergo decomposition to yield an artifact which was isolated by silica gel prep. TLC (eluent: 98:2 CHCl3-MeOH) to afford 3a (1.2 mg).
The crude EtOAc extract (880.0 mg) obtained from the PDB+Cu2+ culture broth (9.0 L) was suspended in MeOH (50.0 mL) and filtered to afford an insoluble (270.0 mg) and soluble (610.0 mg) fractions. The insoluble fraction was subjected to silica gel (50.0 g) column chromatography. Elution with CH2Cl2 afforded 6 (56.0 mg) and 8 (56.5 mg). The soluble fraction was subjected to Sephadex LH−20 (20.0 g) size-exclusion chromatography to obtain five fractions (A−E). Of these, fractions B (232.0 mg) and C (242.0 mg) showed cytotoxic activity. Fraction B was further fractionated on a Sephadex LH−20 (10.0 g) column. Elution with 100 mL each of 4:1 CH2Cl2-hexanes, 3:2 CH2Cl2-acetone, 1:4 CH2Cl2acetone, and MeOH afforded four fractions. Addition of MeOH (5.0 mL) to the fraction obtained with 4:1 CH2Cl2-hexanes fraction (125.0 mg) provided an insoluble material (59.6 mg) consisting mainly of 6. The soluble portion (61.0 mg) was subjected to preparative silica gel TLC (95:5 CH2Cl2-MeOH) followed by C-18 HPLC (75−80% aq. MeOH) to yield 7 (3.0 mg), 6 (24.0 mg), and 4 (1.4 mg). Fraction C obtained above was fractionated on a Sephadex LH−20 (7.0 g) column. Elution with 50.0 mL each of 4:1 CH2Cl2hexanes, 3:2 CH2Cl2-acetone, 1:4 CH2Cl2-acetone, and MeOH gave four fractions. Addition of MeOH (5.0 mL) to the fraction obtained with 4:1 CH2Cl2-hexanes (149.0 mg) provided an insoluble material (26.3 mg) that was found to be pure 8. The soluble portion (110.0 mg) was further separated on a silica gel (5.0 g) column. Elution with 70:30 CH2Cl2-EtOAc afforded 7 (63.0 mg), 6 (7.0 mg), and 8 (10.0 mg).
The crude EtOAc extract (130.0 mg) derived from PDB+AA culture (9.0 L) when examined by HPLC indicated the presence of three metabolites (Fig. 1B). Fractionation of this extract by HPLC [Phenomenex Luna 5 μ C18 (2) 100 Å 10 × 250 mm column, solvent system (60% aq. MeOH in 1–25 min and 100% MeOH), 3 mL/min, UV detection at 220 nm] afforded 1-hydroxydehydroherbarin (3) (0.7 mg), scorpinone (4) (10.7 mg), and ascochitine (6) (3.0 mg). Identities of these were confirmed by comparison (TLC, HPLC, 1H NMR, and LC-MS) with those obtained above from EtOAc extracts derived from PDB and PDB+Cu2+ cultures.
3.5. Palmarumycin CE4 (7)
Off-white gum; [α]20D – 41 (c 0.33, CHCl3); UV (MeOH) λmax nm (log ε) 298 (4.02), 306 (sh, 3.86), 312 (3.86), 327 (3.76); 1H NMR (400 MHz, CDCl3): δ 7.55 (1H, dd, J = 0.8, 8.6 Hz, H-5’), 7.53 (1H, dd, J = 0.8, 8.3 Hz, H-4’), 7.45 (1H, dd, J = 7.6, 8.3 Hz, H-3’), 7.44 (1H, dd, J = 7.6, 8.6 Hz, H-6’), 7.04 (1H, dd, J = 0.8, 7.6 Hz, H-2’), 6.95 (1H, dd, J = 0.8, 7.6 Hz, H-7’), 6.00 (1H, ddd, J = 1.2, 2.2, 10.0 Hz, H-5), 5.88 (1H, ddd, J = 2.2, 4.2, 10.0 Hz, H-7), 4.88 (1H, d, J = 11.0 Hz, 5-OH), 4.70 (1H, t, J = 4.2 Hz, H-8), 4.41 (1H, ddd, J = 2.2, 4.2, 4.2 Hz, H-2), 4.11 (1H, m, H-5), 3.14 (1H, brdd, J = 4.0, 5.0 Hz, H-4a), 2.90 (1H, ddd, J = 1.0, 2.2, 18.3 Hz, H-3), 2.76 (1H, dt, J = 1.2, 4.2 Hz, H-8a), 2.67 (1H, ddd, J = 1.0, 3.4, 18.3 Hz, H-3); 13C NMR (100 MHz, CDCl3): δ 214.7 (C-4), 147.0 (C-8’), 146.8 (C-1’), 137.5 (CH-6), 134.5 (C-4a’), 127.7 (CH-3’), 127.4 (CH-6’), 125.8 (CH-7), 121.8 (CH-5’), 121.2 (CH-3’), 114.0 (C-8a’), 110.0 (CH-2’), 109.3 (CH-7’), 105.9 (C-1), 75.9 (CH-2), 71.7 (CH-8), 69.6 (CH-5), 47.2 (CH-4a), 47.0 (CH2-3), 42.4 (CH-8a); Positive HRMS-ESI m/z 359.0890 [M+Na]+ (calcd for C20H16O5Na: 359.0895).
3.6. Oxidation of palmarumycin CE4 (7) with MnO2
To a solution of 7 (5.7 mg) in CH2Cl2 (2.0 mL) was added freshly prepared MnO2 (50.0 mg) and the reaction was stirred at room temperature for 6 h (TLC control). The reaction mixture was filtered, the filtrate was concentrated and the resulting residue was purified by silica gel column chromatography and eluted with CH2Cl2 to afford the oxidation product (4.2 mg, 73%), which was identified as palmarumycin CP3 (10) by comparison of its data (LRMS, 1H and 13C NMR) with those reported for this compound (Xu et al., 2015).
3.7. Cytotoxicity assay
The resazurin-based colorometric (alamarBlue) assay (Wijeratne et al., 2012) was used for evaluating in vitro cytotoxicity of samples against human non-small cell lung (NCI-H460), human CNS glioma (SF-268), human breast (MCF-7), human metastatic breast adenocarcinoma (MDA-MB-231), metastatic prostate adenocarcinoma (PC-3M), and human Ewing’s sarcoma (CHP-100) cancer cell lines. Doxorubicin and DMSO were used as positive and negative controls, respectively.
Supplementary Material
Highlights.
Secondary metabolite profile of the endophytic fungus, Anteaglonium sp. FL0768, was found to be affected by culture conditions.
Incorporation of Cu2+ enhanced production of metabolites and drastically affected the polyketide biosynthetic pathway.
The histone acetyl transferase inhibitor, anacardic acid, slightly affected the metabolite profile
The epigenetic modifiers, 5-azacytidine and suberoyl anilide hydroxamic acid had no effect on its secondary metabolite profile.
Acknowledgements
Financial support for this work was provided by the U.S. National Cancer Institute (Grant R01 CA090265), U.S. National Institute of General Medical Sciences (Grant P41 GM094060) and CNPq, Brazil [Fellowship awards to JM (Process: 236451/2012–0) and MCFO (Process: 233171/2012–6)]. We are thankful to Drs. A. Elizabeth Arnold and Jana M. UʹRen (University of Arizona) for their help with collection and identification of the fungal strain, Prof. Diego L. V. Oliveira (Departamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Brazil) for providing anacardic acid, Prof. Lijiang Xuan (Shanghai Institute of Materia Medica, PR China) for HRESIMS data, and Ms. Mangping X. Liu (University of Arizona) for conducting cytotoxicity assays.
Footnotes
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in the online version, at https://doi.org/10.1016/j.phytol.xxxx.xx.xxx.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- Albright JC, Henke MT, Soukup AA, McClure RA, Thomson RJ, Keller NP, Kelleher NL, 2015. Large-scale metabolomics reveals a complex response of Aspergillus nidulans to epigenetic perturbation. ACS Chem. Biol 10, 1535–1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aslan A, Altun S, Ahmed I, Florke U, Schulz B, Krohn K, 2011. Synthesis of biologically active nonnatural palmarumycin derivatives. Eur. J. Org. Chem 1176–1188. [Google Scholar]
- Beau J, Mahid N, Burda WN, Harrington L, Shaw LN, Mutka T, Kyle DE, Barisic B, van OA, Baker BJ, 2012. Epigenetic tailoring for the production of anti-infective cytosporones from the marine fungus Leucostoma persoonii. Mar. Drugs 10, 762–774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bode HB, Zeeck A, 2000. UV mutagenesis and enzyme inhibitors as tools to elucidate the late biosynthesis of the spirobisnaphthalenes. Phytochemistry 55, 311–316. [DOI] [PubMed] [Google Scholar]
- Bode HB, Wegner B, Zeeck A, 2000. Biosynthesis of cladospirone bisepoxide, a member of the spirobisnaphthalene family. J. Antibiot 53, 153–157. [DOI] [PubMed] [Google Scholar]
- Calvo AM, Wilson RA, Bok JW, Keller NP, 2002. Relationship between secondary metabolism and fungal development. Microbiol. Mol. Biol. Rev 66, 447–459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choshi T, Kumemura T, Nobuhiro J, Hibino S, 2008. Novel synthesis of the 2-azaanthraquinone alkaloid, scorpinone, based on two microwave-assisted pericyclic reactions. Tetrahedron Lett. 49, 3725–3728. [Google Scholar]
- Chung YM, Wei CK, Chuang DW, El-Shazly M, Hsieh CT, Asai T, Oshima Y, Hsieh TJ, Hwang TL, Wu YC, Chang FR, 2013. An epigenetic modifier enhances the production of anti-diabetic and anti-inflammatory sesquiterpenoids from Aspergillus sydowii. Bioorg. Med. Chem 21, 3866–3872. [DOI] [PubMed] [Google Scholar]
- Cichewicz RH, 2010. Epigenome manipulation as a pathway to new natural product scaffolds and their congeners. Nat. Prod. Rep 27, 11–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Colombo L, Gennari C, Ricca SG, Scolastico C, 1980. Biosynthetic origin and revised structure of ascochitine, a phytotoxic fungal metabolite. Incorporation of [1-13C]- and [1,2-13C2]-Acetates and [Me-13C]Methionine. J. Chem. Soc. Perkin Trans. I 675–676. [Google Scholar]
- Dreyfuss MM, Chapela IH, 1994. Potential of fungi in the discovery of novel, low-molecular weight pharmaceuticals, In: Gullo VP (Ed.), The Discovery of natural products with therapeutic potential. Butterworth-Heinemann, Boston, pp 49–80. [DOI] [PubMed] [Google Scholar]
- Engelmann C, Illner S, Kragl U, 2015. Laccase initiated CC couplings: various techniques for reaction monitoring. Process Biochem. 50, 1591–1599. [Google Scholar]
- Evidente A, Capasso R, Vurro M, Bottalico A, 1993. Ascosalitoxin, a phytotoxic trisubstituted salicylic aldehyde from Ascochyta pisi. Phytochemistry 34, 995–998. [Google Scholar]
- Fisch KM, Gillaspy AF, Gipson M, Henrikson JC, Hoover AR, Jackson L, Najar FZ, Waegele H, Cichewicz RH, 2009. Chemical induction of silent biosynthetic pathway transcription in Aspergillus niger. Ind. Microbiol. Biotechnol 36, 1199–1213. [DOI] [PubMed] [Google Scholar]
- Fujii I, Yasuoka Y, Tsai H-F, Chang YC, Kwon-Chung KJ, Ebizuka Y, 2004. Hydrolytic polyketide shortening by Ayg1p, a novel enzyme involved in fungal melanin biosynthesis. J. Biol. Chem 279, 44613–44620. [DOI] [PubMed] [Google Scholar]
- Ghizzoni M, Boltjes A, Graaf CD, Haisma HJ, Dekker FJ, 2010. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative. Bioorg. Med. Chem 18, 5826–5834. [DOI] [PubMed] [Google Scholar]
- Gunatilaka AAL, 2006. Natural products from plant-associated microorganisms: distribution, structural diversity, bioactivity, and implications of their occurrence. J. Nat. Prod 69, 509–526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henrikson JC, Hoover AR, Joyner PM, Cichewicz RH, 2009. A chemical epigenetics approach for engineering thein situ biosynthesis of a cryptic natural product from Aspergillus niger. Org. Biomol. Chem 7, 435–438. [DOI] [PubMed] [Google Scholar]
- Hertweck C, 2009. Hidden biosynthetic treasures brought to light. Nat. Chem. Biol 5, 450–452. [DOI] [PubMed] [Google Scholar]
- Krohn K, Michel A, Florke U, Aust A-J, Draeger S, Schultz B, 1994a. Biologically active metabolites from fungi, 4. palmarumycins CP1–CP4 from Coniothyrium palmarum: isolation, structure elucidation, and biological activity. Liebigs Ann. Chem 109, 1093–1097. [Google Scholar]
- Krohn K, Michel A, Florke U, Aust A-J, Draeger S, Schultz B, 1994b. Biologically active metabolites from fungi, 5. palmarumycins C1–C16 from Coniothyrium sp.: isolation, structure elucidation, and biological activity. Liebigs Ann. Chem 109, 1099–1108. [Google Scholar]
- Krohn K, Beckmann K, Floerke U, Aust H-J, Draeger S, Schulz B, Busemann S, Bringmann G, 1997. Biologically active metabolites from fungi, 9. new palmarumycins CP4a and CP5 from Coniothyrium palmarum: structure elucidation, crystal structure analysis and determination of the absolute configuration by CD calculations. Tetrahedron 53, 3101–3110. [Google Scholar]
- Kusari S, Pandey SV, Spiteller M, 2013. Untapped mutualistic paradigms linking host plant and endophytic fungal production of similar bioactive secondary metabolites. Phytochemistry 91, 81–87. [DOI] [PubMed] [Google Scholar]
- Kusnick C, Jansen R, Liberra K, Lindequist U, 2002. Ascochital, a new metabolite from the marine ascomycete Kirschsteiniothelia maritima. Pharmazie 57, 510–512. [PubMed] [Google Scholar]
- Leyte-Lugo M, González-Andrade M, González MC, Glenn AE, Cerda-Garcia-Rojas CM, Mata R, 2012. (+)-Ascosalitoxin and vermelhotin, a calmodulin inhibitor, from an endophytic fungus isolated from Hintonia latiflora. J. Nat. Prod 75, 1571–1577. [DOI] [PubMed] [Google Scholar]
- Mazzetto SE, Lemonaco D, Mele G, 2009. Cashew nut oil: Opportunities and challenges in the context of sustainable industrial development. Quim. Nova 32, 732–741. [Google Scholar]
- McLellan CA, Turbyville TJ, Wijeratne EMK, Kerschen A, Vierling E, Queitsch C, Whitesell L, Gunatilaka AAL, 2007. A rhizosphere fungus enhances Arabidopsis thermotolerance through production of an HSP90 inhibitor. Plant Physiol 145, 174–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newman AG, Vagstad AL, Storm PA, Townsend CA, 2014. Systematic domain swaps of iterative, nonreducing polyketide synthases provide a mechanistic understanding and rationale for catalytic reprogramming. J. Am. Chem. Soc 136, 7348–7362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nutzmann HW, Reyes-Dominguez Y, Scherlach K, Schroeckh V, Horn F, Gacek A, Schumann J, Hertweck C, Strauss J, Brakhage AA, 2011. Bacteria-induced natural product formation in the fungus Aspergillus nidulans requires Saga/Ada-mediated histone acetylation. Proc. Natl. Acad. Sci. U S A 108, 14282–14287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paranagama PA, Wijeratne EMK, Burns AM, Marron MT, Gunatilaka MK, Arnold AE, Gunatilaka AAL, 2007a.. Heptaketides from Corynespora sp. inhabiting the cavern beard lichen, Usnea cavernosa: first report of metabolites of an endolichenic fungus. J. Nat. Prod 70, 1700–1705. [DOI] [PubMed] [Google Scholar]
- Paranagama PA, Wijeratne EMK, Gunatilaka AAL, 2007b.. Uncovering biosynthetic potential of plant-associated fungi: effect of culture conditions on metabolite production by Paraphaeosphaeria quadriseptata and Chaetomium chiversii. J. Nat. Prod 70, 1939–1945. [DOI] [PubMed] [Google Scholar]
- Pettit RK, 2009. Mixed fermentation for natural product drug discovery. Appl. Microbial. Biotechnol 83, 19–25. [DOI] [PubMed] [Google Scholar]
- Pimental-Elardo SM, Sorensen D, Ho L, Ziko M, Bueler SA, Lu S, Tao J, Moser A, Lee R, Agard D, Fairn G, Rubinstein JL, Shoicher BK, Nodwell JR, 2015. Activity-independent discovery of secondary metabolites using chemical elicitation and cheminformatic inference. ACS Chem. Biol 10, 2616–2623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Powis G, Wipf P, Lynch SM, Birmingham A, Kirkpatrick DL, 2006. Molecular pharmacology and antitumor activity of palmarumycin based inhibitors of thioredoxin reductase. Mol. Cancer Ther 5, 630–636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rateb ME, Hallyburton I, Houssen WE, Bull AT, Goodfellow M, Santhanam R, Jaspers M, Ebel R, 2013. Induction of diverse secondary metabolites in Aspergillus fumigatus by microbial co-culture. RSC Advances 3, 14444–14450. [Google Scholar]
- Schüffler A, Liermann JC, Kolshorn H, Opatz T, Anke H, 2009. New naphthoquinone derivatives from the ascomycete IBWF79B-90A. Z. Naturforsch 64, 25–31. [DOI] [PubMed] [Google Scholar]
- Schumacher J, 2016. DHN melanin biosynthesis in the plant pathogenic fungus Botrytis cinerea is based on two developmentally regulated key enzyme (PKS)-encoding genes. Mol. Microbiol 99, 729–748. [DOI] [PubMed] [Google Scholar]
- Shwab EK, Bok JW, Tribus M, Galehr J, Graessle S, Keller NP, 2007. Histone deacetylase activity regulates chemical diversity in Aspergillus. Eukaryotic Cell 6, 1656–1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seibert SF, Eguereva E, Krick A, Kehraus S, Voloshina E, Raabe G, Fleischhauer J, Leistner E, Wiese M, Prinz H, Alexandrov K, Janning P, Waldmann H, Konig GM, 2006. Polyketides from the marine-derived fungus Ascochyta salicorniae and their potential to inhibit protein phosphatases. Org. Biomol. Chem 4, 2233–2240. [DOI] [PubMed] [Google Scholar]
- Upadhyay S, Torres G, Lin X, 2013. Laccases involved in 1,8-dihydroxynaphthalene melanin biosynthesis in Aspergillus fumigatus are regulated by developmental factors and copper homeostasis. Eukaryotic Cell 12, 1641–1652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vagstad AL, Hill EA, Labonte JW, Townsend CA, 2012. Characterization of a fungal thioesterase having Claisen cyclase and deacetylase activities in melanin biosynthesis. Chem. Biol 19, 1525–1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Wagoner RM, Mantle PG, Wright JLC, 2008. Biosynthesis of scorpinone, a 2azaanthraquinone from Amorosia littoralis, a fungus from marine sediment. J. Nat. Prod 71, 426–430. [DOI] [PubMed] [Google Scholar]
- VanderMolen KM, Darveaux BA, Chen W-L, Swanson SM, Pearce CJ Oberlies NH, 2014. Epigenetic manipulation of a filamentous fungus by the proteasome-inhibitor bortezomib induces the production of an additional secondary metabolite. RSC Adv. 4, 18329–18335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vervoort HC, Drašković M, Crews P, 2011. Histone deacetylase inhibitors as a tool to up-regulate new fungal biosynthetic products: isolation of EGM-556, a cyclodepsipeptide, from Microascus sp. Org. Lett 13, 410–413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Von Woedtke T, Lindequist U, Alhitari N, Kusnick C, Julich W-D, Abel PU, 2002. The usefulness of a biosensor controlled perfusion cell culture for the investigation of new drugs demonstrated with the marine fungus Kirschsteiniothelia maritima. Pharmazie 57, 270–274. [PubMed] [Google Scholar]
- Wang XR, Sena JG, Hoover AR, King JB, Ellis TK, Powell DR, Cichewicz RH, 2010. Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an Atlantic-Forest-soil-derived Penicillium citreonigrum. J. Nat. Prod 73, 942–948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wijeratne EMK, Bashyal BP, Gunatilaka MK, Arnold AE, Gunatilaka AAL, 2010. Maximizing chemical diversity of fungal metabolites: biogenetically related heptaketides of the endolichenic fungus Corynespora sp. J. Nat. Prod 73, 1156–1159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wijeratne EMK, Bashyal BP, Liu MX, Rocha DD, Gunaherath KB, U’Ren JM, Gunatilaka MK, Arnold AE, Whitesell L, Gunatilaka AA L, 2012 Geopyxins A–E, entkaurane diterpenoids from endolichenic fungal strains Geopyxis aff. majalis and Geopyxis sp. AZ0066: structure–activity relationships of geopyxins and their analogues. J. Nat. Prod 75, 361–369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wijeratne EMK, Espinosa-Artiles P, Gruener R, Gunatilaka AAL, 2014. Thielavialides A−E, nor-spiro-azaphilones and a bis-spiro-azaphilone from Thielavia sp. PA0001, an endophytic fungus isolated from aeroponically grown Physalis alkekengi. J. Nat. Prod 77, 1467–1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams RB, Henrikson JC, Hoover AR, Lee AE, Cichewicz RH, 2008. Epigenetic remodeling of the fungal secondary metabolome. Org. Biomol. Chem 6, 1895–1897. [DOI] [PubMed] [Google Scholar]
- Wipf P, Jung JK, Rodriguez S, Lazo JS, 2001. Synthesis and biological evaluation of deoxypreussomerin A and palmarumycin CP1 and related naphthoquinone spiroketals. Tetrahedron 57, 283–296. [Google Scholar]
- Xu YM, Mafezoli J, Oliveira MCF, U’Ren JM, Arnold AE, Gunatilaka AAL, 2015. Anteaglonialides A–F and palmarumycins CE1–CE3 from Anteaglonium sp. FL0768, a fungal endophyte of the spikemoss Selaginella arenicola. J. Nat. Prod 78, 2738–2747. [DOI] [PubMed] [Google Scholar]
- Yaegashi J, Oakley BR, Wang CCC, 2014. Recent advances in genome mining of secondary metabolite biosynthetic gene clusters and the development of heterologous expression systems in Aspergillus nidulans. J. Ind. Microbiol. Biotechnol 41, 433–442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yakasai AA, Davison J, Wasil Z, Halo LM, Butts CP, Lazarus CM, Bailey AM, Simpson TJ, Cox RJ, 2011. Nongenetic reprogramming of a fungal highly reducing polyketide synthase, J. Am. Chem. Soc 133, 10990–10998. [DOI] [PubMed] [Google Scholar]
- Zabala AO, Chooi Y-H, Choi MS, Lin H-C, 2014. Fungal polyketide synthase product chainlength control by partnering thiohydrolase. ACS Chem. Biol 9, 1576–1586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zutz C, Gacet A, Sulyok M, Wagner M, Strauss J, Rychli K, 2013. Small chemical chromatin effectors alter secondary metabolite production in Aspergillus clavatus. Toxins 5, 1723–1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




